Sensitivity of the COBAS AmpliScreen™ HIV-1 Test v1.5 for HIV-1 detection

被引：0
|
作者：
Gomez, Lucia P. [1 ,2 ]
Balangero, Marcos C. [1 ,2 ]
Castro, Gonzalo [1 ,3 ]
Kademian, Silvia [3 ]
Mangeaud, Arnaldo [4 ]
Barbas, Maria G. [3 ]
Cudola, Analia [3 ]
de Leon, Juan F. [2 ,3 ]
Carrizo, Horacio [2 ]
Gallego, Sandra V. [1 ,2 ,3 ]
机构：
[1] Univ Nacl Cordoba UNC, Fac Ciencias Med, Inst Virol Dr JM Vanella, Lab Virus Linfotrop Humanos Retrovirus HIV & HTLV, Cordoba, Argentina
[2] Fdn Banco Cent Sangre, Lab Biol Mol, Cordoba, Argentina
[3] Minist Salud, Lab Cent Prov Cordoba, Cordoba, Argentina
[4] UNC, Catedra Estadist & Biometria, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina
来源：
REVISTA ARGENTINA DE MICROBIOLOGIA | 2014年 / 46卷 / 03期
关键词：
NAT; HIV-1; COBAS AmpliScreen; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-DONATIONS; AMPLIFICATION; ARGENTINA; MULTICENTER; INFECTIONS; DONOR; ASSAY; RNA; DNA;
D O I：
10.1016/S0325-7541(14)70072-0
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The introduction of nucleic acid amplification techniques (NAT) in blood banks was intended to reduce the residual risk of transfusion-transmitted infections. Co-circulation of a great diversity of HIV-1 variants in Argentina portrays the need to assess the sensitivity of serological and molecular assays available for their detection. In this study, we evaluated the sensitivity of the COBAS AmpliScreen (TM) HIV-1 Test, version 1.5 (Roche) for the detection of HIV-1 RNA in plasma samples of infected individuals from Argentina. The results of this study reveal that this technique has high sensitivity for the detection of HIV-1 RNA under assay conditions: using mini-pool testing, pools >= 50 RNA copies per ml achieved >= 92 % sensitivity, whereas in the standard procedure, samples >= 207 RNA copies/ml achieved 100 % sensitivity. Moreover, the COBAS AmpliScreen (TM) HIV-1 Test, version 1.5 (Roche) is suitable for detecting prevailing HIV-1 variants. (C) 2014 Asociacion Argentina de Microbiologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：196 / 200
页数：5
相关论文
共 50 条
  • [31] COBAS AmpliScreenTM HCV Test,v2.0 and HIV-1 Test,v1.5 minipool testing:clinical trial update for13U.S.blood centers
    中国输血杂志, 2001, (S1) : 400 - 400
  • [32] Perfomance evaluation of the new Roche Cobas ampliprep Cobas Taqman HIV-1 test version 2.0 for the quantification of HIV-1 RNA
    Pas, S. D.
    Petterson, A.
    Mes, T.
    Rossen, J.
    Schutten, M.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S11 - S11
  • [33] Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT
    Swanson, P
    de Mendoza, C
    Joshi, Y
    Golden, A
    Hodinka, RL
    Soriano, V
    Devare, SG
    Hackett, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 3860 - 3868
  • [34] A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay
    Braun, Patrick
    Delgado, Rafael
    Drago, Monica
    Fanti, Diana
    Fleury, Herve
    Hofmann, Joerg
    Izopet, Jacques
    Kuehn, Sebastian
    Lombardi, Alessandra
    Mancon, Alessandro
    Angeles Marcos, Ma
    Mileto, Davide
    Saune, Karine
    O'Shea, Siobhan
    Perez-Rivilla, Alfredo
    Ramble, John
    Trimoulet, Pascale
    Vila, Jordi
    Whittaker, Duncan
    Artus, Alain
    Rhodes, Daniel
    JOURNAL OF CLINICAL VIROLOGY, 2017, 92 : 75 - 82
  • [35] Improved HIV-1 RNA quantitation by COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 using a novel dual-target approach
    Sizmann, Dorothea
    Glaubitz, Joachim
    Simon, Christian O.
    Goedel, Sebastian
    Buergisser, Philippe
    Drogan, Daniel
    Hesse, Martin
    Kroeh, Michael
    Simmler, Pascale
    Dewald, Manuela
    Gilsdorf, Marion
    Fuerst, Marion
    Ineichen, Ralph
    Kirn, Anette
    Pasche, Paul
    Wang, Zhijun
    Weisshaar, Sabrina
    Young, Karen
    Haberhausen, Gerd
    Babiel, Reiner
    JOURNAL OF CLINICAL VIROLOGY, 2010, 49 (01) : 41 - 46
  • [36] Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR test, version 1.5, on clinical laboratory operations
    Germer, Jeffrey J.
    Bendel, Jordan L.
    Dolenc, Craig A.
    Nelson, Sarah R.
    Masters, Amanda L.
    Gerads, Tara M.
    Mandrekar, Jayawant N.
    Mitchell, P. Shawn
    Yao, Joseph D. C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (09) : 3101 - 3104
  • [37] Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma
    Anastassopoulou, CG
    Toulomi, G
    Katsoulidou, A
    Hatzitheodorou, H
    Pappa, M
    Paraskevis, D
    Lazanas, M
    Gargalianos, P
    Hatzakis, A
    JOURNAL OF VIROLOGICAL METHODS, 2001, 91 (01) : 67 - 74
  • [38] Performance Evaluation of Three Real-Time HIV-1 Viral Load Assays against Amplicor COBAS Monitor v1.5 platform
    McClemon, D.
    Mallan, M.
    Fix, C.
    Hassan, J.
    Conroy, P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 633 - 634
  • [39] Results of the Abbott RealTime HIV-1 Assay for Specimens Yielding "Target Not Detected" Results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test
    Babady, N. Esther
    Germer, Jeffrey J.
    Yao, Joseph D. C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (03) : 969 - 971
  • [40] Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from London:: Comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx® HIV RNA quantitative assays
    Swanson, Priscilla
    Holzmayer, Vera
    Huang, Shihai
    Hay, Phillip
    Adebiyi, Ade
    Rice, Philip
    Abravaya, Klara
    Thamm, Sven
    Devare, Sushil G.
    Hackett, John, Jr.
    JOURNAL OF VIROLOGICAL METHODS, 2006, 137 (02) : 184 - 192
12345